Reckitt CFO Day departs
This article was originally published in The Tan Sheet
Executive SummaryColin Day, Reckitt Benckiser's chief financial officer for 10 years, will leave the organization, the U.K. company says Oct. 22. Day, who as CFO has seen the firm significantly expand its pharmaceutical business, will remain in the position until March 2011 to ensure a smooth transition. A successor will be announced in the next few months, the firm said
You may also be interested in...
The $9.7bn acquisition hinges on the small interfering RNA inclisiran, but an ongoing cardiovascular outcomes trial, manufacturing hurdles, and reimbursement challenges provide subjects for concern.
US congressional leaders and medtech industry advocacy group AdvaMed are giving their full-throated endorsement to a US-Mexico-Canada (USMCA) trade agreement announced by the US Trade Representative's Office on 10 December. See what AdvaMed's president and CEO, Scott Whitaker, said about it in a statement here.